$90.4M
$709,000
0.0% of portfolio
89,674
Q2 2025
Reduced 66.99%
$698M
$29 Million
0.0% of portfolio
3,762,470
Q2 2025
Reduced 4.28%
$6.71M
$260,000
0.0% of portfolio
302,974
Q2 2025
Reduced 25.47%
$14.6B
$23.2 Million
0.0% of portfolio
158,130
Q2 2025
Added 21.89%
$163M
$83,000
0.0% of portfolio
48,774
Q2 2025
Reduced 36.66%
$627M
$1.53 Million
0.0% of portfolio
17,787
Q2 2025
Reduced 6.6%
Transcode Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
$382M
$210,000
0.0% of portfolio
4,931
Q2 2025
New
Translational Dev Acquisitio
-
$0
0.0% of portfolio
-
Q1 2025
New
$2.2B
$30.8 Million
0.0% of portfolio
11,909,694
Q2 2025
Reduced 1.99%
$4.41B
$260,000
0.0% of portfolio
10,063
Q2 2025
Reduced 37.22%
$4.92B
$24.6 Million
0.0% of portfolio
477,440
Q2 2025
Added 138.38%
$93.6M
$131,000
0.0% of portfolio
17,531
Q2 2025
Reduced 61.49%
$1.12B
$23 Million
0.0% of portfolio
1,556,852
Q2 2025
Added 79.43%
$362M
$1.38 Million
0.0% of portfolio
235,155
Q2 2025
Reduced 9.41%
$259M
$526,000
0.0% of portfolio
59,872
Q2 2025
Reduced 39.7%
$1.02B
$5 Million
0.0% of portfolio
257,589
Q2 2025
Added 25.83%
$428M
$1.64 Million
0.0% of portfolio
299,045
Q2 2025
Added 41.14%
$6.72B
$29.8 Million
0.0% of portfolio
547,447
Q2 2025
Reduced 33.46%
$3.44B
$18.1 Million
0.0% of portfolio
566,938
Q2 2025
Reduced 43.91%
$1.43B
$22 Million
0.0% of portfolio
544,570
Q2 2025
Reduced 15.39%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 32.75%
$234M
$83,000
0.0% of portfolio
61,550
Q2 2025
New
$1.5B
$3.62 Million
0.0% of portfolio
126,637
Q2 2025
Reduced 14.78%
$20.7B
$32.1 Million
0.0% of portfolio
422,259
Q2 2025
Added 15.5%
$4B
$30.3 Million
0.0% of portfolio
414,063
Q2 2025
Added 1.18%
$555M
$1.37 Million
0.0% of portfolio
97,208
Q2 2025
Reduced 28.87%
$2.34B
$25.5 Million
0.0% of portfolio
943,825
Q2 2025
Added 43.37%
$80.4M
$364,000
0.0% of portfolio
116,901
Q2 2025
Reduced 65.98%
-
$0
0.0% of portfolio
-
Q2 2025
New
$2.28B
$3.08 Million
0.0% of portfolio
236,150
Q2 2025
Added 86.07%
$4.13B
$11.8 Million
0.0% of portfolio
497,401
Q2 2025
Added 62.64%
Trisalus Life Sciences Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 50.4%
$1.57B
$8.53 Million
0.0% of portfolio
132,859
Q2 2025
Added 51.94%
$531M
$8.77 Million
0.0% of portfolio
1,729,833
Q2 2025
Added 26.09%
$125M
$732,000
0.0% of portfolio
85,844
Q2 2025
Reduced 43.77%
$417M
$1.5 Million
0.0% of portfolio
117,571
Q2 2025
Added 7.96%
$171M
$656,000
0.0% of portfolio
345,477
Q2 2025
Reduced 10.92%
$0
$0
0.0% of portfolio
565,608
Q2 2025
Added 25.88%
$2.06B
$17.9 Million
0.0% of portfolio
323,723
Q2 2025
Added 82.22%
Trust For Professional Manag
-
$0
0.0% of portfolio
-
Q2 2025
New
Trust For Professional Manag
-
$0
0.0% of portfolio
-
Q2 2025
New
$665M
$8.12 Million
0.0% of portfolio
242,967
Q2 2025
Reduced 16.5%
$2.35B
$17.5 Million
0.0% of portfolio
480,058
Q2 2025
Added 1.98%
$715M
$2.48 Million
0.0% of portfolio
99,410
Q2 2025
Reduced 21.46%
$31.6M
$623,000
0.0% of portfolio
430,070
Q2 2025
Added 152.46%
-
$0
0.0% of portfolio
-
Q2 2025
Added 62.75%
$170M
$1.57 Million
0.0% of portfolio
326,074
Q2 2025
Reduced 42.32%
$4.77B
$28.3 Million
0.0% of portfolio
693,533
Q2 2025
Reduced 59.35%
$222M
$201,000
0.0% of portfolio
10,239
Q2 2025
Reduced 72.42%